Immunogenicity Assay Development & Screening
Cambridge Bioscience offer access to an immunoassay development and screening service from Haematologic Technologies, Inc to detect anti-drug antibodies in patient samples enabling researchers to evaluate the immunogenicity of a therapeutic protein. Appropriate controls or reference materials can be developed and manufactured and the assay tests your samples in-house at the cGMP-certified testing facility.
Contct Our Specialists
To request a no obligation quote or further information in relation to a immunogenicity development and screening project, please contact our HTI specialist by Clicking Here